This year the Society for Neuro-Oncology is honored to host the 4th Quadrennial World Federation of Neuro-Oncology (WFNO) meeting in San Francisco from November 21st to the 24th. Meeting chairman Dr. Mitchel Berger extends a warm welcome to members of all neuro-oncology societies to share in this unique educational event.
This year's Education Day entitled "From Drug Discovery to Clinic" will address the various aspects of clinical development of agents that range from preclinical testing, pharmacokinetic and pharmacodynamic considerations, first in man studies and the challenges of phase 0-III clinical trials. Concurrent sessions will address the specific challenges of clinical design and specific pathways that are being evaluated in the preclinical arena. Also featured will be a Quality of Life Session with modules focused on Palliative Care, Symptom Management, and Caregiver Challenges.
This one day registration includes a continental breakfast and a boxed lunch. Attendees are invited to attend the Thursday evening Welcome Reception if travel plans permit.